Ovarian Cancer Market

Ovarian Cancer Market with Chemotherapy
Drugs, 2015 - 2021

P e r s i s t e n c e M a r k e t R e s e a r c h
About Us
Persistence Market Research (PMR) is a market intelligence company, providing global business information
reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking
insight for thousands of decision makers. We have an experienced team of Analysts, Researchers,
and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze
information. Our business offerings represent the latest and the most reliable information indispensable for
businesses to sustain a competitive edge.
Each PMR Syndicated Research report covers a different sector - such as pharmaceuticals, chemical,
energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports
provide in-depth analysis and deep segmentation to possible micro levels. With a wider scope and stratified
research methodology, our syndicated reports strive to serve clients and satisfy their overall research
requirement.
Copyright © 2015 Persistence Market Research
All Rights Reserved. This document contains highly confidential information and is the sole property of PMR.
No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of PMR.
Ovarian Cancer Market, 2015 - 2021 Page |

P e r s i s t e n c e M a r k e t R e s e a r c h
Report Media Releases
Ovarian Cancer Market with Chemotherapy Drugs, 2015 - 2021
Ovarian cancer is a type of cancer that begins in the ovaries. Ovarian cancer is the most common type of cancer among
women. Epithelial tumor, stromal tumor and germ cell tumors are the type of ovarian cancer. Pelvic discomfort,
abdominal pressure, urinary urgency, swelling, low back pain, loss of appetite, change in bladder habits and lack of
energy are some of the sign and symptoms for the ovarian cancer. Ovarian cancer is diagnosed with the help of pelvic
examination, blood test, ultrasound and other tests such as MRI, PET and CT. Lack of early warning symptoms and
early diagnostic tests for detection are the major causes of high rate of death due to ovarian cancer. It is one of the
common causes of cancer death in women. According to World Cancer Research Fund International, in 2012, 239,000
new cases of ovarian cancer were detected. Globally, it constitutes about 1.7% of all cancer cases in 2012. Inherited
gene mutation, estrogen hormone replacement therapy, polycystic ovary syndrome and fertility treatment may increase
risk of ovarian cancer. Some of the complications in ovarian cancer is it can spread to other organs such as abdominal
cavity, pelvis and abdominal lymph nodes, bones, liver, brain and sac surrounding the lymph nodes. The treatment of
ovarian cancer is based on the stage of the disease. The treatment includes surgery, chemotherapy, radiation and
biological therapy. Ovarian cancer is most chemo-sensitive cancer. The chemotherapy drugs are more effective when
given in combination with radiation therapy.
Request to view TOC : http://www.persistencemarketresearch.com/toc/3671
North America dominates the global market for ovarian cancer due to large number of aging population. Asia is expected
to show high growth rates in the next five years in the global ovarian cancer market. China and India are expected to
be the fastest growing ovarian cancer markets in Asia-Pacific region. Some of the key driving forces for ovarian cancer
market in emerging countries are rise in healthcare expenditure, large pool of patients and rising government funding.
In recent times there is increased in ovarian cancer due to increasing aging population of women. Increasing prevalence
of ovarian cancer, introduction of new drugs and therapies, increase in healthcare expenditure and increased
government funding are some of the key factors driving the growth for global ovarian cancer market. In addition,
increasing healthcare awareness is also fuelling the growth of global ovarian cancer market. However, subsequent
launch of generic drugs and patent expiration of blockbuster drugs, such as Taxol, Gemzar, Paraplatin and Hycamtin
are some of the major factors restraining the growth for global ovarian cancer market.
Lack of accurate diagnosis of ovarian cancer could lead a challenge for the global ovarian cancer market. Some of the
trends for the global ovarian cancer market are increasing in funding activity and use of combination therapy for the
treatment of ovarian cancer. Some of the major companies operating in the global ovarian cancer market are Bristol
Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Janssen Pharmaceuticals, Inc., Novogen, Inc.,
Genentech Inc., Aetera Zenteris Inc., Boehringer Ingelheim GmbH and F. Hoffman-La Roche Ltd.
Key geographies evaluated in this report are:
North America
o U.S
o Canada
Europe
o France, Germany, Italy, Spain, and the UK
o Eastern Europe
o CIS
APAC
o China
o India
o Japan
o Australia
Ovarian Cancer Market, 2015 - 2021 Page |

P e r s i s t e n c e M a r k e t R e s e a r c h
o Others
Latin America
o Argentina
o Brazil
o Others
Request to view Sample Report : http://www.persistencemarketresearch.com/samples/3671
Key features of this report
Drivers, restraints, and challenges shaping the Ovarian Cancer market dynamics
Latest innovations and key events in the industry
Analysis of business strategies of the top players
Ovarian Cancer market estimates and forecasts(2015 -2021)
For information regarding permissions, contact:
Persistence Market Research
90 Sate Street, Suite 700 Albany, NY 12207
Tel: +1-518-618-1030
Email: sales@persistencemarketresearch.com
Website: http://www.persistencemarketresearch.com/
media@persistencemarketresearch.com
Ovarian Cancer Market, 2015 - 2021 Page |